Ticker
Germany blocks AstraZeneca vaccine for over-65s
By EUobserver
Germany will not recommend the use of the Oxford/AstraZeneca coronavirus on its over-65 population, citing "insufficient data", according to a statement on Thursday from the Robert Koch Institute. The AstraZeneca vaccine, at the centre of a row over supplies to the EU, is expected to be approved by the European Medical Agency on Friday. This decision only applies to Germany. The vaccine is already in use in the UK.